Diffusion-weighted imaging negative M232R familial Creutzfeldt-Jakob disease

J Clin Neurosci. 2019 Jun:64:47-49. doi: 10.1016/j.jocn.2019.03.019. Epub 2019 Mar 22.

Abstract

The familial Creutzfeldt-Jakob disease (fCJD) usually has similar clinical and neuroimaging features as sporadic CJD (sCJD). A 57-year-old man presented with a four-month history of rapidly progressive dementia (RPD). Laboratory tests for RPD were all normal. Brain MRI demonstrated diffuse cortical atrophy and no abnormal cortical or striatal hyperintensities on fluid-attenuated inversion recovery (FLAIR)/diffusion weighted imaging (DWI). Electroencephalography revealed intermittent slow waves in the bilateral hemispheres. Cerebrospinal fluid (CSF) examination showed elevated cell counts and protein concentrations. After 10 days of empirical treatment with antiviral agents, the patient was eventually diagnosed with fCJD with M232R mutation based on the results of positivity for 14-3-3 protein, CSF PrPsc in real-time quaking-induced conversion assay and genetic test for PRNP gene. The striatal or cortical FLAIR/DWI hyperintensities are reliable radiographic markers in the diagnosis of both sCJD and fCJD. However, this case suggests that clinical work-up for CJD including genetic test is essential to do a differential diagnosis of RPD, regardless of FLAIR/DWI findings.

Keywords: Diffusion weighted imaging; Familial Creutzfeldt-Jakob disease; M232R mutation.

Publication types

  • Case Reports

MeSH terms

  • 14-3-3 Proteins / genetics*
  • Creutzfeldt-Jakob Syndrome / diagnostic imaging*
  • Creutzfeldt-Jakob Syndrome / genetics*
  • Creutzfeldt-Jakob Syndrome / pathology
  • Dementia / diagnostic imaging
  • Dementia / genetics
  • Dementia / pathology
  • Diffusion Magnetic Resonance Imaging
  • Humans
  • Male
  • Middle Aged
  • Mutation

Substances

  • 14-3-3 Proteins